LifeMD, Inc.
US ˙ NasdaqGM ˙ US53216B1044

SecurityLFMD / LifeMD, Inc.
InstitutionWealthspire Advisors, LLC
Latest Disclosed Ownership61,664 shares
Latest Disclosed Value $ 222,608
Wealthspire Advisors, LLC ownership in LFMD / LifeMD, Inc.

On May 1, 2026 - Wealthspire Advisors, LLC filed a 13F-HR form disclosing ownership of 61,664 shares of LifeMD, Inc. (US:LFMD) valued at $222,607 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 61,664 shares of LifeMD, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $281,188 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F LIFEMD COM 53216B104 61,664 0 0.00 223 5.71 0.0017
2026-02-12 2025-12-31 13F LIFEMD COM 53216B104 61,664 0 0.00 210 -49.76 0.0017
2025-11-14 2025-09-30 13F LIFEMD COM 53216B104 61,664 0 0.00 419 -50.18 0.0022
2025-08-11 2025-06-30 13F LIFEMD COM 53216B104 61,664 61,664 840 0.0047
2024-08-08 2024-06-30 13F LIFEMD COM 53216B104 0 -61,664 -100.00 0 -100.00
2024-05-06 2024-03-31 13F LIFEMD COM 53216B104 61,664 0 0.00 634 23.87 0.0085
2024-02-07 2023-12-31 13F LIFEMD COM 53216B104 61,664 0 0.00 511 32.73 0.0073
2023-11-06 2023-09-30 13F LIFEMD COM 53216B104 61,664 0 0.00 385 43.66 0.0064
2023-08-01 2023-06-30 13F LIFEMD COM 53216B104 61,664 0 0.00 268 157.69 0.0044
2023-05-09 2023-03-31 13F LIFEMD COM 53216B104 61,664 0 0.00 105 -12.61 0.0018
2023-02-14 2022-12-31 13F LIFEMD COM 53216B104 61,664 0 0.00 120 -1.65 0.0022
2022-11-14 2022-09-30 13F LIFEMD COM 53216B104 61,664 0 0.00 121 -3.97 0.0025
2022-08-09 2022-06-30 13F LIFEMD COM 53216B104 61,664 -836 -1.34 126 -42.99 0.0026
2022-05-09 2022-03-31 13F LIFEMD COM 53216B104 62,500 62,500 221 0.0050
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.